Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.

Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Abstract Text:

Janet K Hess-Wilson,Siobhan L Webb,Hannah K Daly,Yuet-Kin Leung,Joanne Boldison,Clay E S Comstock,Maureen A Sartor,Shuk-Mei Ho,Karen E Knudsen,Janet K Hess-Wilson,Siobhan L Webb,Hannah K Daly,Yuet-Kin Leung,Joanne Boldison,Clay E S Comstock,Maureen A Sartor,Shuk-Mei Ho,Karen E Knudsen,

BACKGROUND: Prostatic adenocarcinomas are dependent on androgen receptor (AR) activity for growth and progression, and therapy for disseminated disease depends on ablation of AR activity. Recurrent tumors ultimately arise wherein AR has been re-activated. One mechanism of AR restoration is via somatic mutation, wherein cells containing mutant receptors become susceptible to activation by alternative ligands, including bisphenol A (BPA). In tumors with specific AR mutations, BPA promotes therapeutic bypass, suggesting significant negative impact to the clinical management of prostate cancer. OBJECTIVE: Our goal was to determine the mechanism of BPA action in cancer cells carrying BPA-responsive AR mutants. METHODS: The molecular signature of BPA activity in prostate cancer cells harboring mutant AR was delineated via genetic microarray analysis. Specificity of BPA action was assessed by comparison with the molecular signature elicited by dihydrotestosterone (DHT). RESULTS: BPA and DHT elicited distinct transcriptional signatures in prostate cancer cells expressing the BPA-responsive mutant AR-T877A. BPA dramatically attenuated estrogen receptor beta (ERbeta) expression; this finding was specific to prostate tumor cells in which BPA induces cellular proliferation. CONCLUSIONS: BPA induces a distinct gene expression signature in prostate cancer cells expressing somatic AR mutation, and a major molecular consequence of BPA action is down-regulation of ERbeta. Since ERbeta functions to antagonize AR function and AR-dependent proliferation, these findings reveal a novel mechanism by which BPA likely regulates cellular proliferation. Future investigation directed at dissecting the importance of ERbeta in the proliferative response to BPA will establish the contribution of this event to adverse effects associated with human exposure.

Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Publishing Authors By Initials

JK Hess-Wilson,SL Webb,HK Daly,YK Leung,J Boldison,CE Comstock,MA Sartor,SM Ho,KE Knudsen,JK Hess-Wilson,SL Webb,HK Daly,YK Leung,J Boldison,CE Comstock,MA Sartor,SM Ho,KE Knudsen,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Environmental health perspectives

VOLUME: 115

Page Numbers: 1646-53

Journal Abbreviation: Environ. Health Perspect.

ISSN: 0091-6765

DAY: 16

MONTH: Nov

YEAR: 2007

Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 330411

Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.

AFFILIATION: Department of Cell and Cancer Biology, University of Cincinnati College of Medicine, Ohio 45267-0521, USA.

Country: United States

AGENCY: United States NIEHS

GRANT: ES93404

ACRONYM: ES

MEDLINETA: Environ Health Perspect

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status Related Publications

• Age Modifies the Pituitary TSH Response to Thyroid Failure.
• Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer.
• Discourses of agency and the search for the authentic self: The case of mood-modifying medicines.
• Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399ile are hypo-responsive to Porphyromonas gingivalis.
• Impact of differential cyclin D1 expression and localisation in prostate cancer.
• Improved parameter estimation for systems with an experimentally located Hopf bifurcation.
• Integrative database management for mouse development: systems and concepts.
• Loss of RB compromises specific heterochromatin modifications and modulates HP1alpha dynamics.
• Migrating with myosin VI.
• Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult.
• Neuroimaging of the serotonin reuptake site requires high-affinity ligands.
• Patterns of organization and management in private and public substance abuse treatment programs.
• Phototoxic furanocoumarins.
• Placental perfusion - a human alternative.
• Psychiatry and torture.
• RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
• RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
• RB loss promotes aberrant ploidy by deregulating levels and activity of DNA replication factors.
• Regulation of cell proliferation in a stratified culture system of epithelial cells from prostate tissue.
• Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression.
• Reprogramming of genetic networks during initiation of the Fetal Alcohol Syndrome.
• Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
• SWI/SNF activity is required for the repression of deoxyribonucleotide triphosphate metabolic enzymes via the recruitment of mSin3B.
• Saint Lucia revisited.
• The human placenta - An alternative for studying foetal exposure.
• Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal.
• Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.
• Variability of estimated binding parameters.
• [Not Available.]
• [Not Available.]